Denovo BioPharma   Report issue

For profit Phase 2 Phase 3
Founded: Beijing China (2011)

Organization Overview

First Clinical Trial
2018
NCT03263026
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Denovo BioPharma | Denovo Biopharma LLC